ShiftBio Partners with RoosterBio to Accelerate Development of a Novel Genetically Engineered Exosome, SBI-102 for Rare Diseases & Cancer April 26, 2022
Univercells Technologies Partners with RoosterBio to Advance Scalable & Continuous Exosomes Manufacture January 20, 2022
RoosterBio Names Life Science Industry Leader, Timothy M. Kelly, Ph.D., as New Chief Executive Officer October 5, 2021
RoosterBio Releases RoosterGEM™, Cell & Gene Therapy’s First Complete Transduction Medium May 20, 2021
RoosterBio Launches Next Generation EV Collection Media as Part of a Complete hMSC-EV Production System December 16, 2020
RoosterBio Collaborates with Sartorius to Expand Cell and Gene Therapy Manufacturing Platform Technology into South Korea December 2, 2020
RoosterBio Signs Cooperative Research and Development Agreement with The Geneva Foundation and the Uniformed Services University September 30, 2020
